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Many bacterial pathogens use the type III
secretion system to inject ‘‘effector’’ pro-
teins into host cells. Here, we report the
identification of a 24 member effector pro-
tein family found in pathogens includingSal-
monella, Shigella, and enteropathogenic
E. coli. Members of this family subvert host
cell function by mimicking the signaling
properties of Ras-like GTPases. The effec-
tor IpgB2 stimulates cellular responses
analogous to GTP-active RhoA, whereas
IpgB1 and Map function as the active forms
of Rac1 and Cdc42, respectively. These
effectors do not bind guanine nucleotides
or have sequences corresponding the con-
served GTPase domain, suggesting that
they are functional but not structural mim-
ics. However, several of these effectors har-
bor intracellular targeting sequences that
contribute to their signaling specificities.
The activities of IpgB2, IpgB1, and Map are
dependent on an invariant WxxxE motif
found in numerous effectors leading to the
speculation that they all function by a similar
molecular mechanism.
INTRODUCTION
Salmonella typhi, Shigella flexneri, and enteropathogenic
Escherichia coli (EPEC) are gram-negative etiological agentsof typhoid fever, bacillary dysentery, and gastroenteritis in
humans. Virulence associated with these enteric bacteria of-
ten correlates with the presence of a functional type III secre-
tion system (TTSS) that acts as a conduit for delivery of bac-
terial ‘‘effector’’ proteins directly into host cells (Cornelis and
Van Gijsegem, 2000; Galan and Collmer, 1999). These se-
creted effectors allow pathogens to limit antibacterial host
immune responses or generate a cellular architecture that
is advantageous to bacterial replication and disease pro-
gression. EPEC, a member of the attaching and effacing
(A/E) pathogen group, intimately attaches to the apical sur-
face of gut epithelia and destroys tight junction barrier func-
tions through the coordinated activities of at least six type III
effectors (Tir, Map, EspF, EspG, EspH, and EspI; Dean et al.,
2005). Unlike EPEC however, Salmonella and Shigella are in-
tracellular pathogens that orchestrate hosT cell invasion and
cellular survival in gut epithelia and immune cells. Each of
these pathogens secretes a distinct set of effector proteins
that propagate their complex intracellular life cycles (Cossart
and Sansonetti, 2004).
Because of their ubiquitous role in cell biology, Ras-like
small G proteins are a common target for virulence factors
secreted by bacterial pathogens (Boquet, 2000). There are
well over 100 eukaryotic small G proteins that regulate a myr-
iad of cellular processes including growth, differentiation,
membrane trafficking, cytoskeletal organization, and nuclear
import. Several key features of small G proteins allow them to
perform these essential functions. First, they act as molecu-
lar switches cycling between GTP bound (active) and GDP
bound (inactive) conformations. Second, most small G pro-
teins are posttranslationally modified; the addition of isopre-
noid lipid moieties allows them to associate with specific
subcellular compartments. Third, they transmit signaling
events in a GTP-dependent manner by activating and/or re-
cruiting downstream target proteins to their sites of action.
Previous studies have identified Salmonella type III bacterial
effectors that function to regulate the cycling of theCell 124, 133–145, January 13, 2006 ª2006 Elsevier Inc. 133
nucleotides bound to the GTPases by mimicking eukaryotic
GTPase-activating proteins (GAPs) and guanine nucleotide
exchange factors (GEFs; Stebbins and Galan, 2001). How-
ever, there are no small G proteins encoded by enteric path-
ogen genomes.
Our interests in the mechanisms of host-pathogen inter-
actions led us to identify a 24 member protein family that
shares sequence similarities to the E. coli type III effector pro-
tein Map. Recent reports demonstrate that Map can induce
hosT cell actin dynamics and disrupts tight-junction barrier
function when delivered by the TTSS (Dean and Kenny,
2004; Kenny et al., 2002). Furthermore, Map is conserved
throughout the A/E pathogens including enterohaemorrha-
gic E. coli (EHEC) and Citrobacter rodentium, suggesting
that it plays an important role in pathogenesis. While the mo-
lecular mechanisms utilized by Map remain undefined,
Dmap strains of C. rodentium are attenuated for virulence
and display colonization defects (Mundy et al., 2004). Inter-
estingly, we have uncovered a number of Map homologs in-
cluding SifA and SifB found in Salmonella and IpgB1 and
IpgB2 found in Shigella. In contrast to the pathogenic func-
tion of Map described above, SifA promotes intracellular
survival and replication by maintaining the integrity of the
Salmonella-containing vacuole (SCV; Beuzon et al., 2000).
Likewise, IpgB1 participates in Shigella invasion by regulat-
ing actin cytoskeleton dynamics (Ohya et al., 2005). Because
these biologically diverse virulence factors are related by
primary sequence, it stands to reason that they all share
a common unidentified biochemical activity to promote bac-
terial pathogenesis.
In this report, we determine the biological function of three
of our 24-member effector protein family, namely IpgB1 and
IpgB2 from Shigella as well as Map from EHEC. As sug-
gested by their sequence relatedness, these three effectors
function in a similar manner by mimicking the GTP-active
form of Rho-family GTPases. Although these bacterial pro-
teins lack many of the biochemical attributes of GTPases,
they induce actin cytoskeletal dynamics in the host cell by
stimulating common signaling pathways. Moreover, the sig-
naling specificities of these type III effector proteins are gov-
erned in part by eukaryotic-like targeting motifs such as PDZ
ligands and CaaX-like sequences at the C terminus. Our
results suggest that direct GTPase mimicry and subcellular
targeting of effectors may be a widely used mechanism in
bacteria-host interactions.
RESULTS
Identification of Bacterial Effector Proteins
with a Shared WxxxE Motif
We performed BLAST database searches starting with the
EHEC effector Map as the index protein. This initial screen
revealed a small number of protein homologs mostly found
in the A/E pathogen group. Each member of this family
shared a common Trp-x-x-x-Glu (WxxxE) motif. Next, we
manually searched our BLAST results for WxxxE-containing
proteins that fell below the significance threshold. By includ-134 Cell 124, 133–145, January 13, 2006 ª2006 Elsevier Inc.ing these ‘‘outliers’’ in multiple PSI-BLAST iterations, we
identified 24 distinct open reading frames that can be subdi-
vided into at least six homolog classes including Map, TrcA,
IpgB1, IpgB2, SifA, and SifB (Figure 1A). Although these pu-
tative effectors share clear regions of sequence similarity
(see Figure S1 in the Supplemental Data available with this
article online), the entire family has only two invariant amino
acids, the Trp and Glu found in the WxxxE signature motif
(Figure 1A, red residues). Secondary structure analysis pre-
dicts that each family member is composed of 6 to 8a helices
that are aligned to well-defined protein sequence bound-
aries, suggesting that they could have a common protein
fold (Figure S1).
IpgB2 Induces Rho-Independent Actin Stress
Fibers’ Assembly
An N-terminal GFP fusion of Shigella IpgB2 induced the
formation of new actin stress fibers upon transfection of
HEK293A cells (Figure 1B), HeLa, and Cos-7 cells (data
not shown). No stress fibers were apparent in cells express-
ing only GFP (Figure 1C). Quantification of these results are
shown in Figure 1F. It seemed likely that the invariant Trp
or Glu residues of the WxxxE motif would be important for
IpgB2 activity. As predicted, neither the Trp62/Ala (Fig-
ure 1D) nor Glu66/Ala (Figure 1E) mutants induced actin
stress fibers. Mutations in the conserved residues Ser72
and Gln76 had no effect on the activity of IpgB2 under these
experimental conditions (Figure 1F).
Activation of the small G protein RhoA induces actin stress
fiber assembly in cells (Ridley and Hall, 1992). To test if IpgB2
is epistatic to RhoA, various inhibitors were used to disrupt
signaling through Rho proteins. The C3-botulinum toxin
was used to irreversibly inhibit RhoA–C (Aktories et al.,
2004). Surprisingly, IpgB2 induced new actin stress fibers
in the presence of the C3-exoenzyme at the same rate as
IpgB2 alone (Figures 2A and 2B). In contrast, C3 abolished
exogenous RhoA-induced stress fiber formation, and severe
retraction fibers were found in these cells (Figures 2C and
2D). To further explore this observation, we performed addi-
tional inhibitor studies. Mutant RhoN19 was used to com-
petitively inhibit Rho guanine-nucleotide exchange factors
(GEFs) in vivo (Ridley and Hall, 1992). In addition, YopT
(Iriarte and Cornelis, 1998), a Yersinia type III effector, was
used to irreversibly block all Rho-family GTPases including
Rho, Rac, and Cdc42 (Figure 2E; Shao et al., 2002). Neither
RhoN19 nor YopT inhibited IpgB2 induced stress fiber for-
mation (Figure 2F, gray bars), whereas they were both potent
antagonists of exogenous RhoA (Figure 2F, black bars).
These inhibitor studies demonstrate that IpgB2 induces actin
stress fiber assembly through a novel mechanism that is in-
dependent of any Rho GTPase activity.
We attempted yeast two-hybrid screens with IpgB2, but
yeast transformants could not be recovered. Therefore, the
readily transformable IpgB2-E66A mutant was used to
screen a 9.5/10.5-day-old mouse embryo library. We identi-
fied three identical clones corresponding to residues 1157–
1329 of Citron kinase (CRIK), a Rho-kinase family member
(Figure 3A). These residues encompass the well-defined
Figure 1. Identification of the WxxxE
Family of Bacterial Effectors
(A) Clustal alignment comparing the WxxxE
region of EHEC Map and 23 other family mem-
bers. Genbank ID# is listed. Invariant residues
are highlighted in red; residues with similar chem-
ical properties are in gray. Nonspecific residues
mutated in mammalian and yeast experiments
are shown in blue. Bacterial species are as
follows: enterohemorrhagic E. coli (EH), entero-
pathogenic E. coli (EP), Citrobacter rodentium
(CR), rabbit enteropathogenic E. coli (rEP) Shi-
gella flexneri (SF), Shigella flexneri 2A (SF0), Shi-
gella dysenteriae (SD) Salmonella typhimurium
(ST), Salmonella enterica (SE), Salmonella enter-
ica serovar typhi (SE0 ), and Salmonella enteritidis
(SN).
(B–E) Immunofluorescence microscopy of
HEK293A cells transfected with GFP-IpgB2 (B),
GFP (C), GFP-IpgB2-W62A (D), and GFP-IpgB2-
E66A (E) and stained with rhodamine phalloidin
to detect actin. Arrows indicate transfected cells.
Scale bar, 15 mm.
(F) Quantification of actin stress fiber assembly in
HEK293A cells transfected with IpgB2 and the
indicated point mutants. One hundred fifty trans-
fected cells were counted in at least three inde-
pendent experiments. Data are presented as
mean ±SEM.Rho binding domain (GBD) of CRIK (Madaule et al., 1995).
CRIK 1157–1329 interacted with both IpgB2-E66A and the
active mutant of RhoA (RhoL63) in a yeast two-hybrid assay
(Figure 3B). Interestingly, the GBD of CRIK is homologous to
the GBD of both ROCKI and ROCKII (Figure 3A), two kinases
that are required for actin stress fiber formation (Amano et al.,
1997).
Both endogenous ROCKI and ROCKII were coimmuno-
precipitated with GFP-IpgB2 but not with control whole-
mouse IgG (Figure 3C). In vitro kinase assays were used
to confirm these protein interactions. GFP-IpgB2 was im-
mune-isolated from HEK293A cells and added to an in vitro
kinase activity assay. Proteins associated with the GFP-
IpgB2 immune complex had significant kinase activity di-
rected toward the S6 substrate peptide (Figure 3D, circles).
We identified the IpgB2-associated kinase as ROCK since
addition of Y27632, a potent ROCK inhibitor, abolished sub-
strate phosphorylation (Figure 3D, triangles). In control ex-
periments, immune-isolated GFP-Map, a homolog of
IpgB2 that also posses a WxxxE motif, had no associated
ROCK kinase activity (Figure 3D, squares). Thus, unidentified
residues or sequences outside the WxxxE motif are likely to
contribute to IpgB2 substrate binding and specificity in vivo.
Consistent with our protein-interaction studies, cells trans-
fected with IpgB2 could not form actin stress fibers upon ap-
plication of the ROCK inhibitor Y27632 (Figure 3E). These
data further implicate ROCK as a critical target of IpgB2 dur-
ing stress fiber formation.It is well established that RhoA induces stress fiber assem-
bly by stimulating the mammalian homolog of Diaphanous
(mDia1; Watanabe et al., 1999). mDia1 is composed of an
N-terminal Rho binding sequence (GBD) followed by the For-
min homology domains 1 and 2 (Figure 3F). IpgB2 specifi-
cally interacted with full-length mDia1 and residues 1–301
encompassing the GBD region (Figure 3G). This data was
confirmed in reciprocal coimmunoprecipitation experiments
(Figure 3H). The WxxxE family member Map did not bind to
any fragment of mDia1, demonstrating the specificity of
these interactions (Figure 3G). Taken together, our results
suggest the possibility that IpgB2 activates Rho GTPase sig-
naling pathways by interacting with Rho ligands via the GBD
domain.
IpgB2 Activates the Rho1p GTPase Signaling
Pathway in Yeast
Our yeast two-hybrid studies suggested that wild-type
IpgB2 is toxic to yeast. We expressed IpgB2 driven off the
GAL1 galactose-inducible promoter and scored yeast
growth when plated on galactose medium. As seen in Fig-
ure 4A, expression of IpgB2 with galactose inhibited yeast
growth, whereas repression of IpgB2 allowed growth. Muta-
tions Trp62/Ala and Glu66/Ala in the WxxxE motif abol-
ished IpgB2 yeast toxicity. In contrast, substitutions at con-
served (but not invariant) residues had no effect on IpgB2
toxicity in yeast (Figure 4A).Cell 124, 133–145, January 13, 2006 ª2006 Elsevier Inc. 135
Figure 2. IpgB2 Induces Rho-Indepen-
dent Actin Stress Fibers
(A–D) HEK293A cells cotransfected with either
0.5 mg of GFP-IpgB2 or HA-RhoA and 3-fold ex-
cess (1.5 mg) pEF control vector or pEF-C3-exo-
enzyme as indicated to the left of each image.
Merged image of IpgB2 or RhoA (green) and actin
(red) in left panel and actin morphology is shown
in the right panel. Scale bar, 15 mm.
(E) YopT cleaves RhoA, Rac1, and Cdc42 from
membranes in HEK293A cells. Membrane frac-
tions (Shao et al., 2002) were probed by Western
blot with the indicated antibodies (top panel) in
the presence of transfected YopT (middle panel).
Cellular ROCK is shown as a loading control (bot-
tom panel).
(F) GFP-IpgB2 (gray bars) or HA-RhoA (black
bars) transfected cells were scored for stress fi-
ber formation in the presence 3-fold excess of
RhoN19 or YopT cDNA. 150 transfected cells
were scored in at least 3 independent experi-
ments. Data are presented as mean ±SEM.To gain additional insights into the mechanism of IpgB2
yeast toxicity, we designed a genetic screening strategy
modeled after the synthetic genetic array (SGA); Tong et al.,
2001). We refer to this technique as a pathogenic genetic ar-
ray (PGA) because it allows an ordered array of5000 viable
yeast-deletion mutants to be assayed for growth defects
associated with conditional expression of any pathogen pro-
tein. We introduced GAL1-IpgB2 into 5000 viable gene-
deletion mutants and examined their growth rates on me-
dium containing galactose (Figure 4B). Since expression of
IpgB2 is toxic to wild-type yeast, any gene-deletion mutant
that grows should identify the corresponding gene as a po-
tential target for IpgB2-induced toxicity. Out of the 5000
strains tested, only gene deletion in BCK1, SLT2, and
RLM1 resulted in a robust growth phenotype. Remarkably,
each of these genes encodes components of the cell-wall
integrity Rho1p/MAP kinase (MAPK) signaling module (Hei-
nisch et al., 1999) illustrated in Figure 4C. It is notable that
PKC1 was not in our gene-deletion library because it has se-
vere growth defects (Figure 4C). In addition, we did not isolate
either MKK1 or MKK2 because these genes are functionally
redundant. While yeast carrying deletions in BCK1, SLT2,
and RLM1 grow well in the presence of IpgB2, deletion of
genes encoding components of other MAPK signaling mod-
ules continue to result in cell toxicity (Figure 4D). Thus, our
PGA screen results are consistent with IpgB2 specifically
subverting the Rho1p signaling pathway.
To test if IpgB2 signaling compares to Rho1p in yeast, we
performed DNA microarray mRNA profiling because overex-
pression of activated Rho1p (Q68H) has a distinct and repro-136 Cell 124, 133–145, January 13, 2006 ª2006 Elsevier Inc.ducible transcriptional profile (Roberts et al., 2000) and
because this is an unbiased method that may determine
other potential IpgB2 functions. DNA microarray analysis of
6000 genes revealed that IpgB2 regulated 351 transcripts
at a 99% confidence level (Figure 4E). The overall IpgB2 tran-
scriptional profile strongly correlates with that of Rho1p-
Q68H (p = 0.632), a value that resembles the correlation
values derived when comparing Rho1p-Q68H to its down-
stream target Pkc1p-R398A (p = 0.709). In contrast, the
IpgB2 profile did not correlate with the profile resulting
from activation of the Cdc42 pheromone response MAPK
cascade induced by overexpression of Ste4p (p = 0.045;
Figure 4E; Whiteway et al., 1990). Consistent with our PGA
screen, the 20 Rlm1p-regulated transcripts (Jung and Levin,
1999) were induced, suggesting that this transcription factor
is indeed activated by IpgB2 (Figure 4F). Therefore, two inde-
pendent genome-screening procedures support the con-
tention that IpgB2 stimulates small G protein signaling events
in a similar manner as GTP bound Rho1p.
WxxxE Family Members Stimulate Distinct Small
G Protein Signaling Events
We screened additional WxxxE bacterial effectors shown in
Figure 1A for the ability to induce actin cytoskeletal dynam-
ics. Transfection of E. coli Map induced cell-surface filopodia
in HEK293A cells (Figure 5A), HeLa, and MDCK cells (not
shown). While filopodia formation was the strongest pheno-
type, lamellipodia extended from the base of the actin pro-
jections (Figure 5A, enlargement). Cells expressing the fol-
lowing mutations in Map, W74/A (data not shown) and
Figure 3. IpgB2 Binds to ROCK and
mDia1 in Cells
(A) Schematic of the Rho-kinase family. Con-
served domains include the kinase domain,
coil/coil, GBD, and Pleckstrin homology domain
(PH). The position of CRIK 1157–1329 is indi-
cated.
(B) Interaction between residues 1157–1329 of
CRIK and IpgB2-E66A or Rho-L63 were as-
sessed by activation of the His reporter gene in
yeast two-hybrid experiments (left panel). Control
histidine supplemented plates are shown in the
right panel.
(C) GFP-IpgB2 transfected cells were immuno-
precipitated (IP) with whole mouse IgG (left lanes)
or anti-GFP monoclonal antibody (right lanes).
Immunoprecipitated samples (IP) or whole-cell ly-
sates (Lysate) were immunoblotted for ROCKI,
ROCKII, or GFP.
(D) ROCK kinase assay was performed on immu-
noprecipitated GFP-IpgB2 (circles) or GFP-Map
(squares). GFP-IpgB2 samples with 10 mM
Y27632 are indicated (triangles). Data is pre-
sented as pmol phosphate incorporated into
the S6 peptide per minute. The average of three
independent experiments and data are pre-
sented as mean ±SEM.
(E) HEK293A cells were transfected with IpgB2
and treated with vehicle alone or with 10 mM
Y27632 at the time of transfection (24 hr) or
1 hr prior to cell fixation (1 hr). At least 150 cells
were counted in at least three independent ex-
periments. Data are presented as mean ±SEM.
(F) Diagram of mDia1 and truncation mutants
used in this study. The GBD and Formin homol-
ogy domains 1 and 2 (FH1 and FH2) are indi-
cated.
(G) HEK293A cells were cotransfected with GFP-
Map or GFP-IpgB2 and the indicated FLAG-
mDia1 plasmids. Anti-GFP immunoprecipitations
(IP) were probed by flag immunoblot (IB) (upper
panel). Cell lysates were probed by FLAG or
GFP immunoblot to show input levels (lower
two panels).
(H) HEK293A cells were cotransfected with the
indicated plasmids. FLAG-mDia1 constructs
were immunoprecipitated (IP) with flag antibodies
and probed by anti-GFP immunoblot (IB). Inputs
were detected by GFP or FLAG immunoblots
(lower two panels). *Cross-reacting band.E78/A (Figure 5B), were indistinguishable from GFP-trans-
fected cells (Figure 5C). Quantification of these results are
shown in Figure 5D. Notably, filopodia formation is a hallmark
of signaling by the small G protein Cdc42 (Nobes and Hall,
1995).
Transfection of Shigella IpgB1 stimulated actin-rich mem-
brane ruffles at the dorsal cell surface of HeLa cells (Figure 5E)
and HEK293A and Cos-7 cells (data not shown). Dorsal ruf-
fles were absent in mutant IpgB1 E80/A (Figure 5F) or flag
vector-expressing cells (Figure 5G). Quantification of these
results are shown in Figure 5H. Notably, the dorsal actin ruf-
fles shown in Figure 5E closely resemble those formed by the
small G protein Rac1 (Nobes and Hall, 1995).Next, we focused on the signaling properties of Map. It is
well established that Cdc42 and Rac1 stimulate the Jun ki-
nase (JNK) signal transduction cascade. JNK activity can
be monitored by its phosphorylation state using phospho-
specific antibodies. Both JNK and its downstream target
c-jun were hyperphosphorylated in Map-transfected cells
but not in Map-E78A-transfected cells (Figure 5I). In control
experiments, the p42/44 MAP kinase (MAPK 1/2) was not
phosphorylated under these conditions, demonstrating that
Map specifically activates the JNK signal transduction path-
way.
We conducted a series of inhibitor studies to determine if
Map is epistatic to Rac1 or Cdc42 (Figure 5J). NeitherCell 124, 133–145, January 13, 2006 ª2006 Elsevier Inc. 137
Figure 4. IpgB2 Induces Signaling in Parallel to Rho1p in Yeast
(A) Yeast transformed with GAL1-IpgB2 or the indicated point mutations were streaked on galactose or glucose containing minimal medium. Experiments
were performed in duplicate.
(B) Pathogenic genetic array. An example of a single 24 16 array plate carrying 348 individual gene-deletion yeast strains that express GAL1-IpgB2 (out
of 16 plates and 5000 strains). All deletion strains were plated in duplicate (diagonal) and spotted to galactose containing minimal medium. The duplicate
bck1D yeast strains expressing GAL1-IpgB2 is shown (enlarged image).
(C) Diagram of the Rho1p-activated Pkc1p/MAPK module. Function of each protein is in parenthesis (T.F. denotes transcription factor). Gene deletions that
allow IpgB2 expressing yeast to survive are boxed in red.
(D) The indicated gene-deletion mutant strains carrying GAL1-IpgB2 were each tested for colony formation on galactose medium. Growth phenotypes on
glucose are shown. fus3 and hog1 are homologous genes of the MAPK slt2.
(E and F) Transcription response signatures of genes whose expression was induced (red) or repressed (green) by expression of PKC1-R398A, Rho1p-
Q68H, IpgB2, and Ste4p for 3 hr are shown. Pearson correlations are indicated above (E). RLM1p target genes and pheromone response genes are
indicated (F).inhibition of cellular GEFs with RacN17 and Cdc42N17 or di-
rect inhibition of Rac1 and Cdc42 by YopT proteolysis could
abrogate Map-induced actin reorganization (Figure 5K).
Both Rac1 and Cdc42 induce F actin nucleation by indirectly
stimulating the Arp2/3 complex via the Wiskott Aldrich Syn-
drome protein (Wasp/Wave) family (Machesky and Insall,
1998). The C-terminal verpolin-cofilin-acidic (VCA) fragment
of Wasp/Wave can inhibit Arp2/3-mediated events (Ma-
chesky and Insall, 1998). We found that VCA domain expres-
sion inhibited actin filopodia induced by Map (Figure 5K). In
control experiments, VCA domain expression also blocked
filopodia formation induced by active Cdc42V12 (data not
shown). However, IpgB2 could stimulate actin stress fiber
formation under similar experimental conditions (data not138 Cell 124, 133–145, January 13, 2006 ª2006 Elsevier Inc.shown), demonstrating that the VCA inhibits specific Arp2/
3-mediated events. These data further suggest that Map
functions operationally similar to IpgB2 as molecular mimic
of GTPases.
WxxxE Effectors Have Functional Eukaryotic
Subcellular Targeting Motifs
We noticed that some WxxxE proteins have putative C-ter-
minal subcellular targeting sequences (Figure 6A, yellow).
In fact, the last three residues of Map (-Thr-Arg-Leu-stop)
conform to a consensus type I PDZ ligand motif (-Ser/Thr-
X-Hydrophobic-stop). To identify binding partners for the
putative PDZ ligand in Map, a mouse embryo library was
screened by the yeast two-hybrid method. We identified
Figure 5. Map and IpgB1 Induce Filopodia and Lamellipodia, Respectively
(A–C) Immunofluorescence microscopy of actin in HEK293A cells transfected with GFP-Map (A) GFP-MapE66A (B), or GFP (C). The boxed region is a mag-
nification of Map induced filopodia. Arrows indicate transfected cells. Scale bar, 15 mm.
(D) Quantification of new filopodia in HEK293A cells transfected with plasmids shown in (A)–(C). One hundred fifty transfected cells were counted in at least
four independent experiments. Data are presented as mean ±SEM.
(E–G) Immunofluorescence microscopy of actin in HEK293A cells transfected with GFP-IpgB1 (E) GFP-IpgB1-E80A (F), or GFP (G). The boxed region is
a magnification of IpgB1 induced lamellipodia. Arrows indicate transfected cells. Scale bar, 15 mm.
(H) Quantification of new lamellipodia in HEK293A cells transfected with plasmids shown in (E) –(G). One hundred fifty transfected cells were counted in three
independent experiments. Data are presented as mean ±SEM.
(I) Whole-cell lysates expressing GFP, GFP-Map, or GFP-Map-E78A were immunoblotted with the indicated antibodies (right) by immunoblot.
(J) Diagram showing the concerted Cdc42 signaling pathway and the inhibitors used in Figure 5K.
(K) HEK293A cells were cotransfected with 0.5 mg of GFP-Map and a 3-fold excess (1.5 mg) of the indicated cDNA inhibitors. At least 150 cotransfected cells
were scored for localized filopodia in three experimental trials. Data are presented as mean ±SEM.seven identical clones corresponding to the second PDZ do-
main of Ezrin binding protein 50 (Ebp50, also known as
NHERF1; Figure 6B). Remarkably, C-terminal VQDTRL* se-
quence is identical to the C terminus of the cystic fibrosis
transmembrane regulator (CFTR), a high-affinity Ebp50 bind-
ing protein (Figure 6C; Short et al., 1998).
To test this interaction in vitro, a recombinant maltose bind-
ing protein (MBP) fusion of either Map or IpgB2 (Figure 6D)
was mixed with recombinant [35S]-labeled Ebp50 produced
in a rabbit reticulocyte in vitro transcription/translation system(Figure 6E). Amylose-Sepharose pull down revealed that
Ebp50 directly interacts with Map but not with control
IpgB2 (Figure 6F). In addition, endogenous Ebp50 interacted
with GFP-Map in co immunoprecipitation experiments, sug-
gesting that Map and Ebp50 form a complex in HEK293A
cells (Figure 6G). In contrast, Ebp50 did not bind to mutant
MapDTRL, confirming that this binding occurs through
a type I PDZ domain interaction (Figure 6G).
Ebp50 is a component of cell surface microvilli where it
functions to target membrane receptors to the apical surfaceCell 124, 133–145, January 13, 2006 ª2006 Elsevier Inc. 139
Figure 6. Map Interacts with Ebp50 through a Conserved PDZ Binding Motif
(A) C-terminal residues of the WxxxE family shown in Figure 1A. Yellow box indicates either type I PDZ ligand or CaaX box.
(B) Diagram of Ebp50 depicting two PDZ domains and the Ezrin/Radixin/Moesin binding domain (ERM). The specific yeast-two hybrid clone of Ebp50 that
interacts with Map is indicated below.
(C) Sequence alignment comparing the C-terminal 8 residues found in Map to those in CFTR. The bacterial or eukaryotic species are indicated.
(D) Coomassie stain of 10 mg of bacterial expressed and purified Map and IpgB2 MBP fusion proteins.
(E) Autoradiograph of 1/20 input of [35S]-methionine labeled Ebp50 produced by an in vitro transcription/translation reaction.
(F) Amylose-Sepharose pull down of MBP-Map or MBP-IpgB2 mixed with [35S]-met-Ebp50. Autoradiograph is shown.
(G) HEK293A cells were transfected with indicated GFP constructs. Cell lysates were immunoprecipitated with anit-Ebp50 antibody and immunoblotted for
GFP (top). Cell lysates were probed anti-GFP immunoblot to show input levels (bottom).
(H and I) Immunfluorescence microscopy HEK293A cells transfected with GFP-Map (H) and GFP-MapDTRL (I). Actin was detected by rhodamine phalloidin
staining and images are shown in gray scale for better contrast (right panels). Scale bar, 15mm.
(J) Quantification of filopodia formation (black bars) or actin stress fibers formation (white bars) in HEK293A cells transfected with the indicated plasmids. At
least 150 cells were counted for three independent experiments. Data are presented as mean ±SEM.of epithelial cells (Bretscher et al., 2000). Thus, Ebp50 may
direct Map to the plasma membrane through the PDZ do-
main interaction. As a functional test of this idea, we ob-
served cell surface filopodia formation in cells expressing140 Cell 124, 133–145, January 13, 2006 ª2006 Elsevier Inc.the Ebp50 binding-deficient mutant MapDTRL. Compared
to the filopodia induced by wild-type Map (Figure 6H), the ac-
tin cytoskeleton in cells expressing MapDTRL (Figure 6I) was
indistinguishable from that of GFP-transfected cells (see
Figure 7. Functional Characterization of
Map during EPEC Pathogenesis
(A and B) Fluorescence microscopy of HeLa cells
infected with EPEC (A) or EPECDmap (B) for 30
min. Images to the left show HeLa cells stained
with rhodamine phalloidin to detect cellular actin
(dotted line) and DAPI (green) to detect EPEC
microcolonies. Images to the right show a 4
magnification of the area indicated by arrows in
the left image. Actin staining is presented in
gray scale to help contrast.
(C and D) HeLa cells infected with EPECDmap
strain carrying plasmids encoding MapE78A
mutant (C) or wild-type Map (D). Cell images are
presented as described in (A) and (B). Scale
bar, 5 mm.
(E) Quantification of filopodia formation in HeLa
cells infected with EPEC or EPECDmap (gray
bars). In addition, EPECDmap carrying the indi-
cated plasmids are shown (white bars). At least
50 EPEC infection sites were scored for the for-
mation of filopodia in three independent experi-
ments. Data are presented as mean ±SEM.
(F) Untransfected, control siRNA, or Ebp50 siRNA-
transfected cells were subjected to Ebp50 (top) or
ROCKII (middle) immunoblot. Average arbitrary
densitometry units from Ebp50 Western blots
were quantified from three independent experi-
ments (bottom).
(G) HeLa cells were transfected with control
siRNA (black bars) or Ebp50 siRNA (white bars).
Twenty-four hours later, cells were infected with
wild-type EPEC or EPECDmap + pmap for 30
min.
(H) Our model postulates that three individual
WxxxE effectors, IpgB2, IpgB1, and Map induce
three distinct actin phenotypes, stress fibers, cell
surface lamellipodia, and filopodia, respectively.
Each of these actin phenotypes are induced by
the GTP bound form of respective RhoA, Rac1,
and Cdc42.Figure 5C). Quantification of these results are shown in
Figure 6J. We asked if subcellular localization could impart
signaling specificity to the WxxxE effectors. As noted in
Figure 6J, IpgB2-expressing cells display stress fiber forma-
tion with an apparent absence of filopodia. We fused the
C-terminal PDZ motif (TRL) of Map to the C terminus of
IpgB2. Transfection of the IpgB2-TRL chimera resulted in
new cell surface filopodia in the majority of cells (Figure 6J).
Coimmunoprecipitation experiments confirmed that Ebp50
interacts with the IpgB2-TRL chimera (data not shown).
These data suggest that Ebp50 is a critical component of
Map signaling and specificity.
Map Activity as a GTPase Mimic and Subcellular
Targeting Are Required for EPEC Pathogenesis
To ensure that our observed phenotypes were not the result
of overexpression of Map in cultured cells, we investigated
host cell filopodia formation in cells infected with EPEC,
a pathogen that naturally expresses Map during infection
(Kenny and Jepson, 2000). EPEC infected HeLa cells pro-
duced cell surface filopodia that surround the bacterial mi-crocolonies (Figure 7A; Kenny et al., 2002). In contrast,
a map gene-deletion strain (EPECDmap) did not induce filo-
podia in host cells (Figure 7B;Kenny et al., 2002). Next, we
introduced expression plasmids carrying the wild-type map
gene (denoted as pmap) or a map gene harboring a single
E78/A point mutation (pmapE78A) into the EPECDmap
strain. While type III delivery of MapE78A failed to induce
cell surface filopodia (Figure 7C), the phenotype was recov-
ered by complementing the EPECDmap with wild-type Map
in trans (Figure 7D). Quantification of these results are shown
in Figure 7E. These data reaffirm the critical role that residues
in the WxxxE motif play for proper function of Map during
EPEC pathogenesis.
Next, we investigated the physiological relevance of Map
targeting to the cell surface through its interaction with
host cell Ebp50. First, we expressed plasmid-encoded
MapDTRL (pmapDTRL) in the EPECDmap strain. As shown
in Figure 7E, type III delivery of MapDTRL failed to induce
filopodia in HeLa cells. To determine if this result is due to
the interaction between Map and Ebp50 we knocked down
Ebp50 protein levels by RNA interference. Ebp50 proteinCell 124, 133–145, January 13, 2006 ª2006 Elsevier Inc. 141
was reduced 70% by specific siRNA treatment com-
pared to controls (Figure 7F). Application of Ebp50 siRNA
to cells 24 hr prior to wild-type EPEC infections signifi-
cantly reduced the incidence of cellular filopodia forma-
tion (Figure 7G). Similar results were found upon infection
of the EPECDmap + pmap strain (Figure 7G). These data
further demonstrate that intracellular targeting by host cell
Ebp50 is required for proper Map function during bacte-
rial pathogenesis.
DISCUSSION
In this study, we have used the Shigella effector IpgB1 and
IpgB2 as well as the E. coli effector Map as experimental pro-
totypes to demonstrate that several WxxxE family members
functionally mimic the activated forms of distinct Rho family
small G proteins (Figure 7H). These results further highlight
the remarkable ability of bacterial effectors to subvert small
G protein signaling pathways through molecular mimicry of
eukaryotic proteins (Stebbins and Galan, 2001).
WxxxE Effectors Are Functional Mimics
of Mammalian Small G Protein
Multiple lines of evidence support our GTPase mimicry pos-
tulate. First, three individual WxxxE effectors, IpgB1, IpgB2,
and Map induce three distinct phenotypes, dorsal ruffles,
stress fibers, and filopodia that normally result from activa-
tion of Rac1, RhoA, and Cdc42, respectively. Whereas
IpgB2 and Map maintained the ability to induce actin cyto-
skeletal changes in the absence of Rho family GTPases, in-
hibition of downstream GTPase signaling pathways abol-
ished the activity of these bacterial effectors. Consistent
with these observations, we found that IpgB2 interacted
with the GBD regions of several natural RhoA ligands. Inter-
estingly, the biological effects of IpgB2 are not restricted to
mammalian cells; PGA analysis suggests that IpgB2 induced
yeast cell death by overstimulating the Pkc1p Rho-kinase
signal transduction pathway. In fact, the gene transcription
profiles induced by IpgB2 compares favorably to that of
GTP bound Rho1p. Finally, we confirmed the role of Map
as a physiological mimic of GTPases with a series of EPEC
infection studies. Thus, our studies provide evidence in sup-
port of a GTPase-independent mechanism for the induction
of critical actin dynamic events.
We aligned our effector protein family using the invariant
WxxxE motif as a molecular signature of functionality. This
initial criterion was proven correct as mutations in the invari-
ant Trp or Glu residues inhibited the GTPase mimicry activity
of IpgB1, IpgB2, and Map. These effector proteins appear to
be a bacterial ‘‘invention’’ since there are no WxxxE motifs in
eukaryotic small G proteins and IpgB1, IpgB2, nor Map bind
guanine nucleotides or display sequences, suggesting that
they have GTPase activity. It is unlikely that two invariant res-
idues could impart this remarkable signaling specificity. We
imagine that the sequences surrounding the WxxxE motif
may also contribute to binding and induce a conformational
switch in GBD-containing target proteins. This scenario
would be analogous to the mechanisms that have been pro-142 Cell 124, 133–145, January 13, 2006 ª2006 Elsevier Inc.posed for GTP bound small G proteins affecting their down-
stream targets (Lei et al., 2000). Since this is only specula-
tion, additional structural data showing WxxxE effectors
bound to their downstream target proteins should provide in-
sights into the molecular mechanisms of GTPase mimicry.
Does Our Model Fit with the Known Properties
of Other WxxxE Effectors?
Based on the function of IpgB1, IpgB2, and Map it may be
possible to infer the activities of additional WxxxE family
members. In light of this information, we now recognize
that the Salmonella effector SifA displays cell-signaling char-
acteristics analogous to members of the Rab subfamily of
small G proteins. For instance, SifA has been suggested to
regulate membrane trafficking to the intracellular vacuole
that houses Salmonella in the host cell cytoplasm (Beuzon
et al., 2000). In addition, SifA plays a role in extending the
Salmonella-inducible filament (Sif) membrane networks along
the microtubule cytoskeleton (Beuzon et al., 2000; Brumell
et al., 2002; Stein et al., 1996). Consistent with this observa-
tion, a recent report demonstrates that SifA recruits kinesin
motor proteins to the Sif membranes through the adaptor
protein SifA-kinesin-interacting protein (SKIP; Boucrot et al.,
2005). Similarly, Rab GTPases direct membrane fusion
events and are required for membrane trafficking along cyto-
skeletal networks by coupling motor proteins to cognate
membranes. Thus, the biological function of SifA is in agree-
ment with our hypothesis that effectors from this family are
likely to possess GTPase mimicry capabilities.
Guided Missiles: Localizing WxxxE Effectors
Determine Their Signaling Specificity
Several of the WxxxE effectors have evolved sequences that
serve as localization determinants in the host cell. For exam-
ple, we identified a functional eukaryotic PDZ ligand at the C
terminus of Map. Remarkably, VQDTRL sequence is identi-
cal to the well-characterized PDZ ligand found in eukaryotic
CFTR. Consistent with this finding, both Map and CFTR in-
teract with the adaptor protein Ebp50 through a PDZ/ligand
interaction. Although this is only speculation, the PDZ motif
of Map most likely acts as an apical membrane retention se-
quence since Ebp50 is highly enriched in this cellular com-
partment and this is the site of enteric E. coli type III secretion.
Because bacterial effectors are injected at low concentra-
tions, specific eukaryotic targeting sequences could direct
these effectors to specific sites within the host cell. Future
experimentation will be aimed at understanding the physio-
logical role of Map as a functional mimic of GTPases at the
apical surface of intestinal epithelial cells.
Interestingly, eukaryotic targeting sequences seem to be
common among the WxxxE effector family. For example,
SifA also possesses a functional C-terminal targeting motif
that is quite similar to the C-terminal CaaX box found in
many eukaryotic small G proteins (Figure 6A, yellow; Boucrot
et al., 2003). In fact, this CaaX motif is required for targeting
SifA to newly forming Salmonella inducible filaments, a pro-
cess that is necessary for its proper signaling function
(Boucrot et al., 2003). Therefore, at least two WxxxE family
members, Map and SifA, have evolved functional C-terminal
targeting motifs that are used by eukaryotic proteins. We ex-
pect other WxxxE effector will be localized to specific host
cell compartments through yet-to-be-identified targeting se-
quences.
Pathogenic Genetic Array: Using Yeast to Study
Bacterial Effector Proteins
Yeast can serve as an excellent model organism to study
bacterial effector protein functions (Lesser and Miller,
2001). We have describing two high-throughput genome-
screening procedures used to elucidate the functions of spe-
cific effectors that are toxic to yeast. The PGA screen illus-
trated in Figure 3B was designed based on previously
described synthetic lethality screens and the SGA screen
(Tong et al., 2001). In addition, we used DNA microarray ex-
pression profiling as a second method to analyze the role of
IpgB2 in yeast. Although we used these genome screening
procedures as an unbiased conformation of our mammalian
cell biology data, the PGA screen, and DNA microarray pro-
filing may serve as useful tools to help identify the functions of
other pathogen effector proteins or toxins that target-
specific substrates in yeast.
Conclusion
Our studies suggest for the first time that IpgB1, IpgB2, and
Map function by a common molecular mechanism as func-
tional mimics of distinct Rho family GTPases. As shown in
Figure 7H, IpgB2 induces actin stress fibers, IpgB1 induces
dorsal lamellipodia, and Map induces cell surface filopodia.
The respective GTPases RhoA, Rac1, and Cdc42 share
these phenotypes. Future studies should reveal the actions
of additional WxxxE effectors, findings that may provide
important new insights into both eukaryotic small G protein
signaling pathways and bacterial pathogenic mechanisms.
EXPERIMENTAL PROCEDURES
Plasmids and siRNA
The map gene (accession # AP002566) was cloned from EHEC O157:H7
genomic DNA, and the ipgb1 (CAA33379) or ipgb2 gene (AF348706)
were cloned from Shigella flexneri pWR100 virulence plasmid (ATCC)
by PCR. Map and IpgB2 were cloned in frame into pEGFP-C2 (Clontech)
and IpgB1 was cloned into FLAG-tagged pcDNA3.1 following standard
protocols. All GTPase constructs were purchased from the Guthrie Insti-
tute. Dr. Jeffrey Frost provided pEF-C3 exoenzyme. ROCKI and mDia1
cDNAs were provided Dr. Shuh Narumiya. For expression in yeast,
ipgb2 was cloned into pYes-DEST52 (Gal1 promoter) using Gateway
technology (Invitrogen). For bacterial complementation, the EHEC map
gene was subcloned down stream of the lacZ promoter in pBBR1MCS1,
a plasmid that replicates autonomously in E. coli. All point mutations were
generated with the QuickChange Site-Directed Mutagenesis kit (Strata-
gene) following manufacturer’s instructions. All constructs were verified
by DNA sequencing. Ebp50 siRNA sequence (50-GGAGAACAGUCGU
GAAGCCtt) or control siRNA were purchased from Ambion.
Cell Culture, Transfection, siRNA, Immunocytochemistry,
and Fluorescence Microscopy
HEK293A cells were maintained as previously described (Shao et al.,
2002). Transfections were performed using FuGENE 6 (Roche). siRNA
tranfections were performed using siPORT amine (Ambion). To assesscell morphology, cells were seeded on fibronectin-coated coverslips
(BD Bioscience) and cultured overnight in 6-well dishes. Cells were trans-
fected for 16–20 hr, fixed and processed for immunocytochemistry.
Immunofuorescence microscopy was performed on a Zeiss Axiovert
200M microscope using the appropriate filter sets and Metafluor soft-
ware.
Immunoprecipitation, Immunoblotting, and Antibodies
Transfections were performed for 16–24 hr, followed by lysis in IP buffer
(20 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1 mM EDTA, 1% Triton
X-100, and protease inhibitor cocktail Roche]). Recombinant proteins
were immunoprecipitated using protein A Sepharose (Invitrogen)-conju-
gated primary antibodies. Anti-GFP polyclonal and monoclonal (Clon-
tech), anti-myc 9E10 (Roche), anti-FLAG M2, anti-FLAG polyclonal, and
anti-HA (Covance) were used for immunoblotting.
ROCK Kinase Assay
Ten centimeter dishes of HEK293A cells were transfected with myc-
ROCKI and GFP-IpGB2, GFP-Map, or GFP alone. Anti-GFP immuno-
precipitated proteins were washed with IP buffer followed by extensive
washes in kinase buffer (20 mM Tris-HCl [pH 7.4], 10 mM MgCl2,
1 mg/ml BSA, 1 mM DTT). Samples were resuspended in 200 ml kinase
buffer and split into two samples, one was left untreated and the other
was incubated for 15 min at 4ºC with Y27632 (10 mM). The second set
of samples contained no inhibitor. 1mCi [32P]-ATP and 1 mM S6 peptide
(QIAKRRRLSSLRA, single amino acid code) were added to the reaction
mix and placed at 30ºC. Ten microliter samples were removed at given
time points and spotted on p81 Whatman paper. Samples were washed
six times in 80 mM phosphoric acid, dried, and Cherenkov units were
counted. Data was graphed using Prism software.
Yeast Two-Hybrid and Yeast Toxicity Assays
Yeast two-hybrid experiments were performed as described previously
(Hollenberg et al., 1995). All yeast transformations were carried out by
standard lithium acetate method. Approximately six million clones were
screened by IpgB2-E66A and 10 million clones were screened by
Map. For yeast toxicity assays, Saccharomyces cerevisiae (strain INVsc1,
Invitrogen) were grown on minimal medium + 2% glucose to repress
GAL1-IpgB2 expression. Expression of GAL1-IpgB2 or mutants was
induced by plating yeast on medium with 2% galactose as the carbon
source. For all assays, transformed yeast colonies were incubated at
30ºC for 48 hr.
Pathogenic Genetic Array
GAL1-IpgB2 was introduced in the yeast strain Y7092 (MATa can1D::
STE2pr-SpDhis5 his3D1 leu2D0 ura3D0 met15D0 lyp1D trp1D::GAL1-
IpgB1-URA3). Briefly, GAL1-IpgB2 was PCR amplified and the PCR
product contained 55 nucleotides of the trp1 gene at the 50 end and
a 25 bp unique region at the 30 end. A second PCR amplification pro-
duced the ura3 gene containing the corresponding 25 bp unique region
at the 50 end and the terminal 55 bp of the trp1 gene at the 30 end.
Both PCR products were transformed into Y7092, and recombinants
were selected on minimal medium minus uracil. The PGA analysis was
conducted using the SGA methodology, as described in Tong et al.
(2001) with the following modifications: double-mutant meiotic progeny
were selected on medium containing glucose, moved to medium contain-
ing raffinose, then transferred to and scored on galactose medium.
Yeast DNA Microarray
Strains containing the following expression plasmids,GAL1-driven IpgB2,
RHO1-Q68H, PKC1-R398A, and STE4 (R. Sopko and B. Andrews) were
induced in 2% galactose for 3 hr. Preparation of samples for hybridization
to microarrays, image acquisition, and data analyses were carried out as
previously described (Grigull et al., 2004). Pearson correlations of micro-
array data from paired combinations of experiments were determined
using Excel software.Cell 124, 133–145, January 13, 2006 ª2006 Elsevier Inc. 143
Bacterial Infections and Complementation
HeLa cells were infected for 30 min with preactivated EPEC as described
previously (Kenny et al., 2002). Complementation plasmid pBBR1MCS1
carrying the EHEC map, mapE78A, or mapDTRL gene was introduced
into EPECDmap strain (B. Kenny) using triparental mating procedure
with the mobilization plasmid pRK2013.
Supplemental Data
Supplemental Data include one figure and can be found with this article
online at http://www.cell.com/cgi/content/full/124/1/133/DC1/.
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